ข่าว/ความเคลื่อนไหว
TENTATIVE PROGRAM
Monday, October 13, 2014
08:00 – 08:45 | REGISTRATION |
09:00 |
OPENING CEREMONY: - Opening Address of Prof. Dr. HRH Princess Chulabhorn Mahidol(Chulabhorn Research Institute, Thailand) |
09:15 |
Keynote Lecture: (Title to be announced) – Prof. Dr. HRH Princess Chulabhorn Mahidol(Chulabhorn Research Institute, Thailand) |
Session I: Genetic Profiles of Cancer | |
09:45 |
Trans-ethnic exploration of liver cancer genome - Tatsuhiro Shibata (National Cancer Institute, Tokyo, Japan) |
10:30 |
Towards integrated “omics” for personalized treatment of breast cancer- Anne-Lise Borresen-Dale (Institute for Cancer Research, Norwegian Radium Hospital, Norway) |
11:15 | Break |
11:45 |
Hypothesis based genomics as a tool to query clinically relevant essential biology in cancer- Zoltan Szallasi (Technical University, Lyngby, Denmark) |
12:30 |
The new driver-based classification of breast cancer: 10 distinct molecular entities- Carlos Caldas (Cambridge Research Institute, UK) |
13:15 | LUNCH |
Session II: Therapeutic Targets and Drugs | |
14:15 |
Development of targeted cancer therapeutics - Axel Ullrich(Max Planck Institute of Biochemistry, Germany) |
15:00 | Recent successes in targeted anti-cancer therapy - Alex Matter(Experimental Therapeutics Centre, Singapore) |
15:45 | Break |
16:15 |
Disrupting arginine metabolism with apoptotic inducing agents:A new paradigm in treating arginine dependent tumors - Niramol Savaraj (University of Miami, USA) |
Tuesday, October 14, 2014
Session III: Experimental Therapeutics: Models | |
09:00 |
Regulation of self-renewal in cancer stem cells - Pier Giuseppe Pelicci (European Institute of Oncology, Italy) |
09:45 |
The critical role of extracellular matrix and microenvironment in metastasis and dormancy- Mina Bissell (Lawrence Berkeley National Laboratory, USA) |
10:30 | Break |
11:00 |
Precision medicine for colorectal cancers - Alberto Bardelli (University of Torino, Italy) |
11:45 |
Tackling the heterogeneity of brain tumors - Joan Seoane (Vall d’Hebron Institute of Oncology, Spain) |
12:30 | LUNCH |
Session IV: Tumor-Host Relationships | |
13:30 |
Remodeling of collagen architecture can mirror immunological changes of tissue microenvironment: new insights for targeting treatments - Luca Vannucci (Institute of Microbiology, Academy of Sciences of the Czech Republic, Czech Republic) |
14:15 |
MHC antigens and the immune escape of cancer - Federico Garrido (University Hospital Virgen de las Nieves, Spain) |
15:00 | Break |
15:30 |
Effects of tumor acidity of immune microenvironment and therapeutic strategies based on pH modulation - Licia Rivoltini (National Cancer Institute, Italy) |
Session V: Translational Investigations | |
16:15 |
Precision cancer medicine at Dana Farber Cancer Institute - William Hahn (Dana Farber Cancer Institute, USA) |
Wednesday, October 15, 2014
Session V: Translational Investigations | |
09:00 |
Rapid approval of new cancer drugs after Phase I - Bruce Chabner (Harvard University, USA) |
09:45 |
New therapies for hepatocellular carcinoma - Lynn G. Feun (Sylvester Comprehensive Cancer Center, USA) |
10:30 | Break |
11:00 |
Dissecting colorectal cancer in multiple targetable diseases- Josep Tabernero (Vall d’Hebron Institute of Oncology, Spain) |
11:45 |
Use of mechanism based evidence for the development of therapy for human cancers - William W. Au (Shantou University Medical College, P.R. China) |
12:30 |
Cancer-related fatigue–symptoms, diagnosis and therapy - Kurt S. Zänker (University of Witten/Herdecke, Germany) |
13:15 | LUNCH |
14:15 |
Concluding Remarks: - Kurt S. Zänker (University of Witten/Herdecke, Germany) |
ข้อมูลจาก : สถาบันวิจัยจุฬาภรณ์
คุณสามารถเลือกการตั้งค่าคุกกี้โดยเปิด/ปิด คุกกี้ในแต่ละประเภทได้ตามความต้องการ ยกเว้น คุกกี้ที่จำเป็น
คุกกี้ประเภทนี้มีความจำเป็นต่อการให้บริการเว็บไซต์ของ สวรส เพื่อให้ท่านสามารถเข้าใช้งานในส่วนต่าง ๆ ของเว็บไซต์ได้ รวมถึงช่วยจดจำข้อมูลที่ท่านเคยให้ไว้ผ่านเว็บไซต์ การปิดการใช้งานคุกกี้ประเภทนี้จะส่งผลให้ท่านไม่สามารถใช้บริการในสาระสำคัญของ สวรส. ซึ่งจำเป็นต้องเรียกใช้คุกกี้ได้